Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Tofacitinib taken by mouth helps treat hair loss in children.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

MK-5108 is safe and shows potential against tumors, especially alone.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Erlotinib may cause scarring hair loss.

Minoxidil helps prevent hair loss from chemotherapy in rats.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.